Related Experiment Video

Updated: May 20, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Pediatric multiple sclerosis

Ellen M Mowry, Emmanuelle Waubant

    Continuum (Minneapolis, Minn.)
    |July 20, 2012
    PubMed

    Insights

    Pediatric multiple sclerosis (MS) presents unique challenges, with environmental and genetic risk factors identified. Children with MS may experience more severe symptoms and earlier disability onset compared to adults.

    Area of Science:

    • Neurology
    • Pediatrics
    • Immunology

    Background:

    • Multiple sclerosis (MS) rarely begins in childhood, with unknown precise incidence.
    • Distinguishing pediatric MS from acute disseminated encephalomyelitis is challenging in young children.

    Purpose of the Study:

    • To summarize the current understanding of pediatric MS.
    • To highlight differences in presentation, risk factors, and outcomes between pediatric and adult MS.
    • To review treatment approaches for pediatric MS.

    Main Methods:

    • Literature review of pediatric MS studies.
    • Analysis of epidemiological data and clinical presentations.
    • Assessment of environmental and genetic risk factors.

    Main Results:

    • Identified risk factors for pediatric MS include Epstein-Barr virus, smoking, and HLA-DRB1*15.
    • Pediatric MS may involve more posterior fossa lesions and higher relapse rates.
    • Pediatric MS is linked to earlier disability onset despite potentially longer time to disability.

    Conclusions:

    • Pediatric MS has distinct characteristics from adult MS.
    • Further research is needed on the efficacy and safety of disease-modifying therapies in children.

    More Related Videos

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla08:51

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

    Published on: February 19, 2021

    Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy07:20

    Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

    Published on: August 9, 2024

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...